Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae

Po-Lin Chen, Jing Jou Yan, Chi Jung Wu, Hsin Chun Lee, Chia-Ming Chang, Nan-Yao Lee, Nai-Ying Ko, Li Rong Wang, Hsin-I Shih, Ching Chi Lee, Wen-Chien Ko

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Optimal antimicrobial therapy for infections due to ertapenem-resistant Enterobacteriaceae remains undetermined. In this study, a diabetic patient with recurrent pyomyositis and osteomyelitis caused by extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae developed ertapenem resistance after imipenem/cilastatin treatment, which was a currently recommended therapy. He was finally treated successfully using tigecycline. Ertapenem resistance was in part explained by the production of SHV-type ESBL and the absence of an outer membrane protein, OmpK36. Our observation suggests that tigecycline may be an alternative for invasive infections caused by ESBL-producing Enterobacteriaceae with decreased susceptibility to carbapenem.

Original languageEnglish
Pages (from-to)312-314
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume68
Issue number3
DOIs
Publication statusPublished - 2010 Nov 1

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae'. Together they form a unique fingerprint.

Cite this